moxiclav forte 312.50mg/5ml powder for oral suspension
medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - amoxicillin, clavulanic acid - powder for oral suspension - clavulanic acid 62.5 mg/5ml amoxicillin 250 mg/5ml - antibacterials for systemic use
moxiclav 1g film-coated tablets
medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 875 mg clavulanic acid 125 mg - antibacterials for systemic use
moxiclav 1.2g powder for solution for injection or infusion
medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - clavulanic acid, amoxicillin sodium - powder for solution for infusion or injection - amoxicillin sodium 1000 mg clavulanic acid 200 mg - antibacterials for systemic use
filgrastim hexal
hexal ag - filgrastim - neutropenia; hematopoietic stem cell transplantation; cancer - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone-marrow transplantation considered to be at increased risk of prolonged severe neutropenia.the safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.mobilisation of peripheral blood progenitor cells (pbpcs).in children and adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (anc) of of ≤ 0.5 x 109/l, and a history of severe or recurrent infections, long-term administration of filgrastim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.treatment of persistent neutropenia (anc ≤ 0.5 x 109/l), and a history of severe or recurrent infections, long-term administration of filgrastim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.in patients with advanced hiv infection, in order to reduce the risk of bacterial infections when other therapeutic options are inappropriate.
zarzio
sandoz gmbh - filgrastim - neutropenia; hematopoietic stem cell transplantation; cancer - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone-marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.mobilisation of peripheral blood progenitor cells (pbpc).in children and adults with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (anc) of ≤0.5 x 109/l, and a history of severe or recurrent infections, long term administration of filgrastim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.treatment of persistent neutropenia (anc ≤ 1.0 x 109/l) in patients with advanced hiv infection, in order to reduce the risk of bacterial infections when other therapeutic options are inappropriate.
carvedilol 3.125mg tablets
tillomed laboratories ltd - carvedilol - oral tablet - 3.125mg
cefuroxime 250mg tablets
tillomed laboratories ltd - cefuroxime axetil - oral tablet - 250mg
ondansetron 4mg tablets
bristol laboratories ltd - ondansetron hydrochloride dihydrate - oral tablet - 4mg
moxiclav bis 457mg/5ml powder for oral suspension
medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - amoxicillin, clavulanic acid - powder for oral suspension - amoxicillin 400 mg/5ml clavulanic acid 57 mg/5ml - antibacterials for systemic use
clavoton 1g tablets film-coated
medochemie ltd- factory b - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - tablets film-coated - 875mg+ 125mg (14/2x7/) in blister